期刊文献+

血浆中单硝酸异山梨酯的高效液相色谱法测定 被引量:5

Determination of isosorbide-5-mononitrate in Human Plasma by HPLC with UV Detection
暂未订购
导出
摘要 目的 :建立了高效液相色谱法测定血浆中单硝酸异山梨酯浓度。方法 :采用硅胶分析柱 ,以二氯甲烷 -正己烷 -乙腈 -甲醇 (92∶4∶1 5∶2 5 )为流动相 ,卡马西平作内标。样品在碱性条件下用二氯甲烷萃取浓集后进样 ,2 34nm波长下检测 ,按内标法定量。结果 :标准曲线在 2 5~ 16 0 0 μg·L-1范围内有良好线性 ,最低检测浓度为 10 μg·L-1,方法回收率为 96 %~ 10 4% ,日内RSD小于 4 5 % ,日间RSD小于 5 %。结论 :本法具有快速简便 ,灵敏准确等特点 ,已用于单硝酸异山梨酯缓释制剂生物利用度测定 ,结果良好。 Objective:This paper establishes a high performance liquid chromatography for the determination of isosorbide-5-mononitrate(ISMN) in human plasma using carbamazepine as the internal standard.Method:a variable wavelength UV detector and Nuclbosil 5 silica 100A column(250 mm×4 6 mm, 5 μm ) were used. The alkalinized plasma sample was extracted with 3 0 mL methylene chloride . After evaporation of the organic layer, the residue was dissolved in mobile phase and injected onto a column. The mobile phase of methylene chloride-hexane-acetonitrile-methanol(92∶4∶1 5∶2 5) was pumped at 2 0 mL·min -1 through the column. The detector at 0 005 AUFS was set at 234 nm.Results:The retention times for ISMN and carbamazepine were 6 4 min and 7 0 min respectively. Standard curve was linear in the concentration range of 25 to 1 600 μg·L -1 . The detection limit in plasma was 10 μg·L -1 ; and method recovery was 96%~104%; within day RSD less than 4 5%; inter-day RSD less than 5%.Conclusion:This method was found to be simple, rapid, sensitive and accurate for determination of ISMN in human plasma.
出处 《药物分析杂志》 CAS CSCD 北大核心 2000年第3期165-167,共3页 Chinese Journal of Pharmaceutical Analysis
关键词 单硝酸异山梨酯 高效液相色谱 血药浓度 isosorbide-5-mononitrate,HPLC,plasma concentration
  • 相关文献

参考文献4

二级参考文献5

共引文献32

同被引文献31

  • 1胡玉钦,侯艳宁,薛洪源,曾强,刘会臣.高效液相色谱-质谱联用测定人血浆中单硝酸异山梨酯[J].中国医院药学杂志,2004,24(9):531-533. 被引量:11
  • 2何秀兰,王传中.注射用阿魏酸钠治疗冠心病充血性心力衰竭疗效观察[J].河北医学,2004,10(11):982-984. 被引量:6
  • 3何林,余继英,吴正中,孙世明.反相高效液相色谱法测定血浆中的单硝酸异山梨酯[J].色谱,2005,23(5):528-530. 被引量:9
  • 4孙学惠,郭涛,隋因,宋洪涛,刘涛.5-单硝酸异山梨酯脉冲控释片的家犬体内药动学[J].药学服务与研究,2006,6(1):21-24. 被引量:3
  • 5Lauro-Marty C, Lartigue-Mattei C, Chabard J L, Beyssac E, Aiache J M, Madesclaire M. J Chromatogr B, 1995, 663(11): 153
  • 6HUTT V,BONN R,FRITSCHI E,et al.Evaluation of the pharmacokinetics and absolute bioavailability of three isosorbide-5-mononitrate preparations in healthy volunteers[J].Arzneim-Forsch,1995,45(2):142-145.
  • 7KRAMER W G.Absorption of isosorbide-5-mononitrate at specific sites in the gastrointestinal tract[J].J Clin Pharmacol,1994,34(12):1218-1221.
  • 8NIOPAS I,DAFTSIOS A C,NIKOLAIDIS N.Relative bioavailability of two isosorbide dinitrate sublingual tablet formulations administered as single doses in healthy subjects[J].Int J Clin Pharmacol Ther,2001,39(5):224-228.
  • 9LAURO-MARTY C,LARTIGUE-MATTEI C,CHABARD J L,et al.Gas chromatographic-mass spectrometric determination of isosorbide 5-mononitrate in human plasma[J].J Chromatogr B Biomed Appl,1995,663(1):153-159.
  • 10POMMIER F,GAUDUCHEAU N,PINEAU V,etal.Simultaneous determination of isosorbide dinitrate and its mononitrate metabolites in human plasma by capillary gas chromatography with electron capture detection[J].J Chromatogr B Biomed Appl,1996,678(2):354 359.

引证文献5

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部